Company: LGN
Filing Date: 2025-05-14
Form Type: DRS/A
Source: 0000950123-25-005247
Chunk: 53

Company: Legence Corp.
Filing Date: 2025-05-14
Form: DRS/A
Chunk 53
---
 Standards Board (the “FASB”), the SEC and various other governing bodies. A change in GAAP could have a significant effect on our reported financial results. Additionally, the adoption of new or
revised accounting principles could require that we make significant changes to our systems, processes and controls. We cannot predict the effect of future changes to accounting principles, which could have a significant effect on our reported
financial results and/or our business, financial condition and results of operations.

If we fail to remediate any material weaknesses or to maintain effective internal control over financial reporting, our ability to accurately and timely report our financial results could be adversely affected.

As a private company, we are not currently required to comply with the rules of the SEC implementing Section 404 of the Sarbanes-Oxley Act of
2002 (“SOX”) and are therefore not required to make a formal assessment of the effectiveness of our internal control over financial reporting for that purpose. Upon becoming a public company, we will be required to comply with the
SEC’s rules implementing Sections 302 and 404 of SOX, which will require management to certify financial and other information in our quarterly and annual reports and provide an annual management report on the effectiveness of control over
financial reporting. Though we will be required to disclose changes made in our internal controls and procedures on a quarterly basis, we will not be required to make our first annual assessment of our internal control over financial reporting
pursuant to Section 404 until the year following our first annual report required to be filed with the SEC. Our independent registered public accounting firm will be required to attest to the effectiveness of our internal control over financial
reporting pursuant to Section 404.

33

Confidential Treatment Requested by Legence Corp.

Pursuant to 17 C.F.R. Section 200.83

In connection with the audit of our financial statements for the year ended December 31,
2024, we and our independent registered public accounting firm, identified certain control deficiencies in the design and implementation of our internal control over financial reporting that in aggregate constituted a material weakness. A material
weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our financial statements will not be prevented or detected on a
timely basis. We did not design and implement effective general information technology controls (“GITCs”), for multiple business units’ information systems that are relevant to the preparation of the consolidated financial statements.
Specifically